Immune Cell Engineering: Targeting Checkpoint Inhibitors

In course

Non dolore laborum quis fugiat sint. Mollit laborum est ea enim est do nisi ullamco elit laboris. Occaecat mollit fugiat irure occaecat labore eiusmod cillum fugiat enim commodo.

Description

This lecture covers the engineering of immune cells for cancer immunotherapy, focusing on targeting checkpoint inhibitors using various delivery techniques such as liposomes and microneedles. It discusses strategies for better drug release control and the use of platelets for post-surgery checkpoint inhibitor delivery.

Instructor

mollit ex

Culpa ullamco irure proident aliqua do ex cupidatat dolore. Aliquip minim voluptate sunt qui anim labore labore. Incididunt incididunt ea veniam anim nostrud exercitation pariatur sint mollit dolore magna qui. Ex aliqua officia laboris consectetur eu commodo non culpa ad voluptate sunt est.

Official source

https://mediaspace.epfl.ch/media/0_qhuybxcu

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Ontological neighbourhood

Health sciences

Immunology: Immune system

Cardiology: Cardiovascular disease

Neurology: Topics in neurology

Biology

Cell biology: Cancer, Blood, Cell signaling

Biological engineering

Biomedical engineering: Genetic engineering

Related lectures (390)